Simple Data. Smarter Risk Insights.
Smarter Risk Insights.
A New Approach to
Brain Aneurysm Prevention, ANRISK®
A New Approach to
Brain Aneurysm Prevention, ANRISK®
ANRISK® is an AI-powered platform that analyzes brain aneurysm risk using routine health screening data, helping organizations support proactive preventive care.
1 in 50 people may have an
unruptured brain aneurysm—often without symptoms.
At least 1 in 50 people have an unknown brain aneurysm
Mortality rate in case of rupture
Treatability rate when detected and treated early
.
.
.
However, brain vascular imaging such as MRA and CTA is difficult to use as a routine screening tool for everyone due to cost, accessibility, and potential risks.
Assess Your Risk
Without Imaging
ANRISK® analyzes routine health screening data to identify individuals at elevated risk of brain aneurysm, helping determine who may benefit from further diagnostic imaging.
No Additional Tests Required
Basic Info
Name, Sex, Date of screening, Date of birth, Chart number
Screening Info
Hemoglobin, Fasting glucose, Total cholesterol, etc (10 data sets)
Measurents
Height, Weight, Waist circumference, Blood pressue
Additional Info
Family history, smoking status
Our Simple Analysis Workflow
Step 1
Upload Health Screening
Data
Upload health screening results to platform
Step 2
AI-Based
Risk Assessment
Run analysis in bulk or individually
Step 3
Personalized
Risk Reports
Download comprehensive reports for all analyzed individuals
Step 4
Follow-up Care for High-Risk Individuals
Identify high-risk individuals and recommend specialist consultation.
Identify Brain Aneurysm Risk
with Personalized ANRISK® Reports
Identify Brain Aneurysm Risk with Personalized ANRISK® Reports
AI based
risk score
Calculates a risk score, which is categorized into one of 5 risk level groups.
Analysis of key factors
Visualizes the key factors influencing your risk score.
Summary of areas of attention
Highlights indicators that may benefit from lifestyle improvement.
Personalized follow-up guide
Provides personalized health management guidance based on individual results.
AI Technology Supported by Published Research
ANRISK® is based on AI technology validated through research published in Scientific Reports, demonstrating strong predictive performance and effective risk stratification.
38.5× higher prevalence in the highest-risk group than in the lowest-risk group*
80% of individuals with a brain aneurysm were classified as high or highest risk.
*Prevalence: The likelihood that a brain aneurysm is present and confirmed through an imaging scan at the time of the health screening.
Who is ANRISK® for?
Hospitals/Medical Institutions
Generate New Revenue Without Additional Equipment
Expand your health screening services with AI-powered risk assessment.
Corporation
Identify High-Risk Individuals Earlier
Support proactive health management through early risk identification and follow-up care.
Start preventive
brain aneurysm care
with ANRISK®
Leave us an inquiry to learn more about our platform.
We’ll provide a proposal, a sample report,
and a schedule link to book a consultation with our team.
Leave us an inquiry to learn more about our platform.
We’ll provide a proposal, a sample report, and a schedule link to book a consultation with our team.